Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePOLARIX: A PHASE 3 STUDY OF POLATUZUMAB VEDOTIN (POLA) PLUS R‐CHP VERSUS R‐CHOP IN PATIENTS (PTS) WITH UNTREATED DLBCL.AuthorsTilly, H.; Flowers, C.; Friedberg, J.W.; Herbaux, C.; Morschhauser, F.; Sehn, L.H.; Sharman, J.; Trněný, M.; Lee, C.; Salles, G.SubjectsANTIMITOTIC agents; ANTIBODY-drug conjugatesPublicationHematological Oncology, 2019, Vol 37, p68ISSN0278-0232Publication typeArticleDOI10.1002/hon.36_2629